A detailed history of New York State Common Retirement Fund transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 34,308 shares of CRBU stock, worth $71,703. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,308
Previous 34,308 -0.0%
Holding current value
$71,703
Previous $56,000 19.64%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$1.62 - $5.05 $123 - $383
76 Added 0.22%
34,308 $56,000
Q1 2024

May 07, 2024

SELL
$4.82 - $8.26 $81 - $140
-17 Reduced 0.05%
34,232 $176,000
Q4 2023

Feb 01, 2024

BUY
$3.58 - $6.25 $67,529 - $117,893
18,863 Added 122.6%
34,249 $196,000
Q3 2023

Nov 07, 2023

BUY
$4.08 - $8.14 $1,558 - $3,109
382 Added 2.55%
15,386 $74,000
Q2 2023

Aug 07, 2023

SELL
$4.04 - $5.47 $270 - $366
-67 Reduced 0.44%
15,004 $64,000
Q1 2023

May 02, 2023

SELL
$4.3 - $7.78 $200,908 - $363,504
-46,723 Reduced 75.61%
15,071 $80,000
Q4 2022

Jan 30, 2023

SELL
$5.57 - $11.01 $22 - $44
-4 Reduced 0.01%
61,794 $388,000
Q3 2022

Nov 08, 2022

BUY
$5.34 - $12.79 $94,699 - $226,817
17,734 Added 40.25%
61,798 $652,000
Q2 2022

Aug 04, 2022

SELL
$5.1 - $9.74 $102,372 - $195,511
-20,073 Reduced 31.3%
44,064 $239,000
Q1 2022

May 05, 2022

BUY
$8.42 - $15.32 $359,449 - $654,010
42,690 Added 199.05%
64,137 $589,000
Q4 2021

Feb 02, 2022

BUY
$14.59 - $23.26 $59,614 - $95,040
4,086 Added 23.54%
21,447 $324,000
Q3 2021

Nov 02, 2021

BUY
$15.75 - $30.29 $273,435 - $525,864
17,361 New
17,361 $414,000

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $127M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.